R&D spending: Here are the Top 10 firms

9. GlaxoSmithKline

  • close
    More than 11,000 solar panels are being deployed onto GlaxoSmithKline Consumer Healthcare's regional distribution center in York, Pa. Last year, the pharmaceutical giant spent $6.2 billion in R&D worldwide.
    View Caption
  • About video ads
    View Caption
of

The London-based pharmaceutical company invested about $6.2 billion in R&D, a 12.7 percent increase from 2008. That’s the largest jump of any Top 10 company, according to Booz & Co. GlaxoSmithKline was the fourth-largest pharmaceutical company based on revenue in 2009, reporting almost $46 billion, and formed in 2000 after a merger between GlaxoWellcome and SmithKline Beecham, both of London. With 13 R&D locations worldwide, the company has its sights set on new products. Recent developments include an H1N1 vaccine and a patent pool to investigate neglected tropical diseases.

2 of 10

Read Comments

View reader comments | Comment on this story

Loading...

Loading...

Loading...

Save for later

Save
Cancel

Saved ( of items)

This item has been saved to read later from any device.
Access saved items through your user name at the top of the page.

View Saved Items

OK

Failed to save

You reached the limit of 20 saved items.
Please visit following link to manage you saved items.

View Saved Items

OK

Failed to save

You have already saved this item.

View Saved Items

OK